NYSE:CVS - CVS Health Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $94.71
Forecasted Upside: 9.42 %
Number of Analysts: 17
Breakdown:
0 Sell Ratings
4 Hold Ratings
12 Buy Ratings
1 Strong Buy Ratings

^$86.55 As of 10/20/2021 05:00 PM ET

▲ +1.66 (1.96%)

1 month | 3 months | 12 months

Get New CVS Health Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for CVS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CVS

^$94.71

▲ +9.42% Upside Potential

This price target is based on 17 analysts offering 12 month price targets for CVS Health in the last 3 months. The average price target is $94.71, with a high forecast of $114.00 and a low forecast of $76.00. The average price target represents a 9.42% upside from the last price of $86.55.

Current Consensus is Buy

The current consensus among 17 polled investment analysts is to buy stock in CVS Health. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

2 strong buy ratings
15 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

4/28/2020

2 strong buy ratings
14 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

7/27/2020

2 strong buy ratings
12 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

10/25/2020

1 strong buy ratings
12 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

1/23/2021

0 strong buy ratings
12 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

4/23/2021

1 strong buy ratings
11 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

7/22/2021

1 strong buy ratings
12 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

9/20/2021

1 strong buy ratings
12 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

10/20/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
8/31/2021	Morgan Stanley	Boost Price Target	Top Pick ➝ Overweight	$99.00 ➝ $114.00	High
8/5/2021	Deutsche Bank Aktiengesellschaft	Boost Price Target	Buy	$95.00 ➝ $101.00	High
7/23/2021	Tigress Financial	Reiterated Rating	Buy	$108.00	Low
6/22/2021	Deutsche Bank Aktiengesellschaft	Lower Price Target	Buy	$99.00 ➝ $95.00	Low
5/24/2021	Wells Fargo & Company	Initiated Coverage	Equal Weight	$89.00	N/A
5/19/2021	BMO Capital Markets	Boost Price Target	Positive ➝ Market Perform	$90.00 ➝ $96.00	High
5/19/2021	Barclays	Boost Price Target	Overweight	$92.00 ➝ $100.00	High
5/19/2021	Wolfe Research	Boost Price Target	Positive ➝ Outperform	$82.00 ➝ $93.00	High
5/18/2021	Wells Fargo & Company	Initiated Coverage	Equal Weight	$89.00	Medium
5/12/2021	Mizuho	Boost Price Target	Positive ➝ Buy	$82.00 ➝ $98.00	Low
5/6/2021	Credit Suisse Group	Boost Price Target	Outperform	$91.00 ➝ $100.00	Low
5/6/2021	BMO Capital Markets	Boost Price Target	Market Perform	$82.00 ➝ $90.00	Low
5/5/2021	Citigroup	Boost Price Target		$83.00 ➝ $98.00	Medium
5/5/2021	Jefferies Financial Group	Boost Price Target	Buy	$90.00 ➝ $95.00	Medium
5/5/2021	Raymond James	Boost Price Target	Strong-Buy	$90.00 ➝ $95.00	High
5/5/2021	Royal Bank of Canada	Boost Price Target	Outperform	$80.00 ➝ $91.00	High
4/14/2021	Truist	Boost Price Target		$80.00 ➝ $88.00	Medium
4/14/2021	Truist Securities	Boost Price Target	Buy	$80.00 ➝ $88.00	Low
4/14/2021	Morgan Stanley	Boost Price Target	Overweight	$86.00 ➝ $92.00	Medium
3/23/2021	Guggenheim	Reiterated Rating	Buy ➝ Neutral		Medium
3/17/2021	Guggenheim	Downgrade	Buy ➝ Neutral		Low
1/8/2021	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$90.00	Low
12/14/2020	SVB Leerink	Boost Price Target	Market Perform	$73.00 ➝ $80.00	High
11/11/2020	Piper Sandler	Boost Price Target	Overweight	$72.00 ➝ $76.00	Low
11/9/2020	Cantor Fitzgerald	Reiterated Rating	Overweight		High
11/9/2020	Deutsche Bank Aktiengesellschaft	Lower Price Target	Buy	$104.00 ➝ $101.00	High
9/17/2020	Piper Sandler	Initiated Coverage	Overweight	$72.00 ➝ $72.00	Medium
8/7/2020	Credit Suisse Group	Boost Price Target	Outperform	$75.00 ➝ $90.00	Medium
8/6/2020	Deutsche Bank Aktiengesellschaft	Lower Price Target	Buy	$109.00 ➝ $104.00	Low
8/6/2020	SVB Leerink	Boost Price Target	Market Perform	$72.00 ➝ $73.00	Low
7/9/2020	Royal Bank of Canada	Reiterated Rating	Buy		Low
7/1/2020	SVB Leerink	Initiated Coverage	Market Perform	$72.00	Low
5/14/2020	Credit Suisse Group	Upgrade	Neutral ➝ Outperform	$75.00	Low
5/8/2020	Credit Suisse Group	Reiterated Rating	Hold		Low
5/7/2020	Robert W. Baird	Boost Price Target	Neutral	$62.00 ➝ $66.00	Low
5/7/2020	UBS Group	Lower Price Target	Buy	$85.00 ➝ $79.00	Low
5/7/2020	Citigroup	Lower Price Target	Buy	$86.00 ➝ $75.00	Low
5/7/2020	Morgan Stanley	Boost Price Target	Overweight	$71.00 ➝ $77.00	Low
5/6/2020	Royal Bank of Canada	Reiterated Rating	Buy	$77.00	High
5/6/2020	Oppenheimer	Reiterated Rating	Hold		High
5/4/2020	JPMorgan Chase & Co.	Lower Price Target	Overweight	$97.00 ➝ $94.00	Low
4/24/2020	Tigress Financial	Reiterated Rating	Buy		Medium
4/13/2020	Morgan Stanley	Boost Price Target	Overweight	$70.00 ➝ $71.00	Low
4/13/2020	SunTrust Banks	Lower Price Target	Buy	$90.00 ➝ $80.00	Medium
4/12/2020	Royal Bank of Canada	Reiterated Rating	Buy	$77.00	High
3/27/2020	Morgan Stanley	Lower Price Target	Overweight	$88.00 ➝ $70.00	Medium
3/27/2020	Robert W. Baird	Lower Price Target	Neutral	$73.00 ➝ $62.00	Medium
3/25/2020	Royal Bank of Canada	Lower Price Target		$85.00 ➝ $81.00	Medium
3/19/2020	Credit Suisse Group	Reiterated Rating	Hold	$75.00	Medium
2/18/2020	Deutsche Bank Aktiengesellschaft	Boost Price Target	Buy	$97.00 ➝ $109.00	Low
2/14/2020	Citigroup	Boost Price Target	Buy	$83.00 ➝ $86.00	Medium
2/13/2020	Robert W. Baird	Boost Price Target	Neutral	$70.00 ➝ $73.00	Medium
2/13/2020	UBS Group	Boost Price Target	Buy	$78.00 ➝ $85.00	Medium
2/13/2020	Cantor Fitzgerald	Boost Price Target	Overweight	$85.00 ➝ $90.00	Medium
2/12/2020	Oppenheimer	Initiated Coverage	Hold		Medium
2/12/2020	Cfra	Boost Price Target	Strong-Buy	$85.00 ➝ $86.00	Medium
12/19/2019	JPMorgan Chase & Co.	Boost Price Target	Overweight	$88.00 ➝ $97.00	Low
12/4/2019	Raymond James	Reiterated Rating	Strong-Buy	$80.00 ➝ $90.00	Low
11/8/2019	Mizuho	Boost Price Target	Buy	$71.00 ➝ $82.00	Low
11/7/2019	UBS Group	Reiterated Rating	Buy	$78.00 ➝ $78.00	Low
11/7/2019	Raymond James	Boost Price Target	Strong-Buy	$75.00 ➝ $80.00	Low
11/7/2019	SunTrust Banks	Boost Price Target	Buy	$85.00	Low
11/7/2019	Citigroup	Boost Price Target	Buy	$72.00 ➝ $83.00	Low
10/21/2019	Cowen	Set Price Target	Buy	$76.00	Low
9/27/2019	Royal Bank of Canada	Initiated Coverage	Outperform	$85.00	Low
9/26/2019	Morgan Stanley	Boost Price Target	Overweight	$74.00 ➝ $77.00	Medium
9/12/2019	Bank of America	Boost Price Target	Buy	$72.00 ➝ $75.00	Low
9/12/2019	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy	$91.00	Medium
8/27/2019	Cowen	Reiterated Rating	Outperform	$69.00 ➝ $76.00	Medium
8/11/2019	Morgan Stanley	Reiterated Rating	Buy	$74.00	Low
8/8/2019	Citigroup	Boost Price Target	Buy	$68.00 ➝ $72.00	Medium
8/7/2019	Evercore ISI	Set Price Target	Buy	$63.00	Low
6/5/2019	Mizuho	Set Price Target	Buy	$71.00	Medium
6/5/2019	Standpoint Research	Upgrade	Hold ➝ Buy		High
5/3/2019	BMO Capital Markets	Set Price Target	Hold	$63.00	Low
5/2/2019	Citigroup	Set Price Target	Buy	$74.00	Low
5/2/2019	UBS Group	Lower Price Target	Sell ➝ Sell	$74.00 ➝ $67.00	Low
5/1/2019	Cantor Fitzgerald	Reiterated Rating	Buy	$80.00	Low
4/29/2019	Morgan Stanley	Lower Price Target	Overweight ➝ Overweight	$92.00 ➝ $74.00	Low
4/29/2019	Credit Suisse Group	Downgrade	Outperform ➝ Neutral	$73.00 ➝ $61.00	Medium
4/21/2019	Cantor Fitzgerald	Reiterated Rating	Buy	$80.00	Low
4/18/2019	Raymond James	Lower Price Target	Strong-Buy ➝ Strong-Buy	$90.00 ➝ $75.00	Low
4/18/2019	Guggenheim	Initiated Coverage	Buy ➝ Buy	$90.00 ➝ $75.00	Low
4/15/2019	CIBC	Reiterated Rating	Outperform ➝ Market Perform		Low
4/15/2019	Oppenheimer	Downgrade	Outperform ➝ Market Perform		Low
4/11/2019	Barclays	Set Price Target	Buy	$73.00	High
4/10/2019	BMO Capital Markets	Initiated Coverage	Outperform	$58.00	Medium
4/10/2019	SunTrust Banks	Lower Price Target		$85.00 ➝ $65.00	Low
4/10/2019	Bank of America	Reiterated Rating	Buy	$82.00 ➝ $74.00	Low
3/12/2019	Sanford C. Bernstein	Initiated Coverage	Outperform ➝ Outperform	$76.00	High
3/6/2019	Citigroup	Lower Price Target	Buy ➝ Buy	$94.00 ➝ $68.00	Medium
2/25/2019	Argus	Lower Price Target	Buy ➝ Positive	$100.00 ➝ $80.00	Low
2/22/2019	Morgan Stanley	Set Price Target	Buy	$92.00	Low
2/21/2019	SunTrust Banks	Lower Price Target	Buy	$85.00	Medium
2/21/2019	UBS Group	Lower Price Target	Buy ➝ Buy	$75.00 ➝ $74.00	High
2/21/2019	Loop Capital	Lower Price Target	In-Line ➝ Hold	$68.00	High
2/21/2019	JPMorgan Chase & Co.	Reiterated Rating	Overweight	$91.00	High
2/21/2019	Cantor Fitzgerald	Reiterated Rating	Overweight	$80.00	High
2/20/2019	Wells Fargo & Company	Downgrade	Outperform ➝ Market Perform	$104.00 ➝ $68.00	High
1/17/2019	UBS Group	Initiated Coverage	Buy ➝ Buy	$75.00	Low
1/3/2019	Cantor Fitzgerald	Reiterated Rating	Buy	$96.00	Low
1/3/2019	Bank of America	Reiterated Rating	Buy	$92.00	Low
12/18/2018	Barclays	Initiated Coverage	Overweight ➝ Overweight	$91.00	Medium
12/11/2018	SVB Leerink	Initiated Coverage	Outperform		Medium
12/2/2018	Cantor Fitzgerald	Initiated Coverage	Overweight	$96.00 ➝ $77.84	Low
11/29/2018	The Goldman Sachs Group	Reiterated Rating	Neutral ➝ Neutral	$87.00	Low
11/28/2018	Evercore ISI	Initiated Coverage	Outperform ➝ Outperform	$89.00	Low
11/28/2018	Loop Capital	Set Price Target	Hold	$80.00	High
11/27/2018	Wells Fargo & Company	Boost Price Target	Outperform	$98.00 ➝ $104.00	Medium
11/26/2018	Cantor Fitzgerald	Initiated Coverage	Overweight	$96.00	High
11/13/2018	Argus	Boost Price Target	Buy	$100.00	Low
11/9/2018	Loop Capital	Set Price Target	Hold	$70.00 ➝ $80.00	N/A
11/8/2018	SVB Leerink	Boost Price Target	Outperform ➝ Positive	$85.00 ➝ $95.00	Medium
11/7/2018	Morgan Stanley	Set Price Target	Buy	$80.00 ➝ $100.00	Low
11/7/2018	Royal Bank of Canada	Set Price Target	Buy	$100.00	Medium
10/26/2018	Tigress Financial	Reiterated Rating	Buy		Low
10/25/2018	Wolfe Research	Initiated Coverage	Peer Perform ➝ Peer Perform		Low
10/23/2018	Royal Bank of Canada	Set Price Target	Buy	$99.00	Low
9/18/2018	Royal Bank of Canada	Boost Price Target	Outperform	$101.00	Medium
9/17/2018	Bank of America	Boost Price Target	Buy	$86.00 ➝ $90.00	Medium
8/9/2018	SVB Leerink	Set Price Target	Outperform	$85.00 ➝ $80.00	Low
8/8/2018	Royal Bank of Canada	Reiterated Rating	Positive ➝ Buy	$90.00	Low
7/9/2018	Citigroup	Reiterated Rating	Neutral ➝ Buy	$81.00	Low
7/3/2018	Morgan Stanley	Lower Price Target	Overweight ➝ Overweight	$88.00 ➝ $80.00	Low
6/30/2018	Mizuho	Reiterated Rating	Buy		Low
6/29/2018	Royal Bank of Canada	Lower Price Target	Outperform	$84.00	Medium
6/13/2018	Mizuho	Set Price Target	Buy	$95.00	High
5/7/2018	Loop Capital	Set Price Target	Hold	$68.00	Medium
4/11/2018	Bank of America	Lower Price Target	Buy ➝ Buy	$91.00 ➝ $88.00	Low
4/10/2018	SVB Leerink	Set Price Target	Buy	$85.00	Low
2/27/2018	Bank of America	Initiated Coverage	Buy ➝ Buy	$91.00	Low
2/13/2018	Citigroup	Set Price Target	Neutral ➝ Neutral	$80.00 ➝ $77.00	Low
2/9/2018	SVB Leerink	Set Price Target	Outperform ➝ Buy	$90.00 ➝ $85.00	Low
2/9/2018	Robert W. Baird	Lower Price Target	Neutral ➝ Neutral	$85.00 ➝ $80.00	Low
2/9/2018	Needham & Company LLC	Set Price Target	Strong-Buy ➝ Buy	$100.00 ➝ $98.00	Medium
2/8/2018	Royal Bank of Canada	Set Price Target	Buy	$89.00	Medium
1/30/2018	Needham & Company LLC	Upgrade	Buy ➝ Strong-Buy	$88.00 ➝ $100.00	High
1/24/2018	Mizuho	Set Price Target	Buy	$95.00	Low
1/18/2018	Cowen	Reiterated Rating	Outperform	$81.00 ➝ $99.00	Low
1/8/2018	SVB Leerink	Boost Price Target	Outperform ➝ Outperform	$82.00 ➝ $90.00	Low
1/5/2018	SunTrust Banks	Boost Price Target	Buy	$90.00	High
1/5/2018	Morgan Stanley	Upgrade	Equal Weight ➝ Overweight	$88.00	High
1/4/2018	Raymond James	Upgrade	Outperform ➝ Strong-Buy	$90.00	High
1/4/2018	UBS Group	Upgrade	Outperform ➝ Strong-Buy		High
1/2/2018	Needham & Company LLC	Boost Price Target	Buy	$85.00 ➝ $88.00	Medium
12/26/2017	Tigress Financial	Reiterated Rating	Buy		Low
12/5/2017	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy ➝ Hold		Medium
12/4/2017	Raymond James	Reiterated Rating	Buy		Low
12/4/2017	Royal Bank of Canada	Set Price Target	Buy	$95.00	Low
12/4/2017	Robert W. Baird	Set Price Target	Hold	$77.00	Medium
12/4/2017	Jefferies Financial Group	Set Price Target	Hold	$76.00	Medium
12/4/2017	Loop Capital	Set Price Target	Hold	$73.00	Medium
12/4/2017	Citigroup	Set Price Target	Hold	$76.00	Medium
12/4/2017	SVB Leerink	Set Price Target	Buy	$85.00	High
12/4/2017	Needham & Company LLC	Boost Price Target	Buy	$79.00 ➝ $85.00	High
12/4/2017	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy ➝ Buy	$69.00 ➝ $90.00	High
11/10/2017	Needham & Company LLC	Upgrade	Hold ➝ Buy	$69.02 ➝ $79.00	N/A
11/7/2017	Loop Capital	Lower Price Target	Hold	$83.00 ➝ $73.00	N/A
11/7/2017	Jefferies Financial Group	Lower Price Target	Hold	$86.00 ➝ $76.00	N/A
11/7/2017	SVB Leerink	Reiterated Rating	Hold ➝ Outperform	$90.00 ➝ $85.00	N/A
11/3/2017	Citigroup	Lower Price Target	Neutral	$87.00 ➝ $74.00	N/A
10/29/2017	Cowen	Set Price Target	Buy	$86.00	N/A
10/27/2017	Loop Capital	Reiterated Rating	Hold		N/A
10/27/2017	Robert W. Baird	Reiterated Rating	Hold	$77.00	N/A
10/24/2017	Mizuho	Set Price Target	Buy	$90.00	N/A
10/18/2017	Jefferies Financial Group	Set Price Target	Hold	$86.00	N/A
10/12/2017	SunTrust Banks	Set Price Target	Buy	$85.00	N/A
10/12/2017	Needham & Company LLC	Reiterated Rating	Hold		N/A
10/9/2017	Oppenheimer	Reiterated Rating	Buy	$95.00	N/A
9/19/2017	Royal Bank of Canada	Initiated Coverage	Outperform ➝ Outperform	$95.00	Low
9/15/2017	Jefferies Financial Group	Boost Price Target	Hold ➝ Hold	$82.00 ➝ $86.00	Medium
9/10/2017	Needham & Company LLC	Reiterated Rating	Hold		Low
8/24/2017	Loop Capital	Initiated Coverage	Hold ➝ Hold	$83.00	Low
8/17/2017	Citigroup	Lower Price Target	Neutral	$88.00 ➝ $87.00	Low
8/14/2017	Robert W. Baird	Reiterated Rating	Outperform	$90.00	Low
8/14/2017	Wolfe Research	Downgrade	Outperform ➝ Market Perform	$89.00 ➝ $82.00	Low
7/14/2017	Jefferies Financial Group	Reiterated Rating	Hold	$82.00	Low
7/3/2017	Guggenheim	Reiterated Rating	Buy		Low
6/27/2017	Needham & Company LLC	Initiated Coverage	Hold ➝ Hold		Low
6/27/2017	SVB Leerink	Set Price Target	Buy	$90.00	N/A
6/13/2017	Cowen	Reiterated Rating	Outperform	$86.00	Low
6/9/2017	Jefferies Financial Group	Reiterated Rating	Hold	$82.00	Low
5/3/2017	Evercore ISI	Reiterated Rating	Outperform	$87.00 ➝ $88.00	Low
4/27/2017	Tigress Financial	Initiated Coverage	Buy ➝ Buy		Low
4/4/2017	UBS Group	Reiterated Rating	Buy	$89.00 ➝ $88.00	N/A
4/1/2017	Jefferies Financial Group	Set Price Target	Hold	$82.00	Low
3/28/2017	Guggenheim	Reiterated Rating	Buy	$90.00	Low
3/18/2017	SVB Leerink	Set Price Target	Buy	$90.00	Low
2/28/2017	Bank of America	Reiterated Rating	Buy	$106.67	N/A
2/16/2017	UBS Group	Reiterated Rating	Buy	$88.50 ➝ $89.00	N/A
2/11/2017	SVB Leerink	Set Price Target	Buy	$90.00	N/A
2/10/2017	UBS Group	Set Price Target	Buy	$89.00	N/A
2/9/2017	Evercore ISI	Lower Price Target	Buy	$91.50 ➝ $84.00	N/A
2/8/2017	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Hold	$88.00	N/A
2/6/2017	Atlantic Securities	Downgrade	Overweight ➝ Neutral	$84.00	N/A
2/6/2017	Guggenheim	Reiterated Rating	Buy	$90.00	N/A
2/4/2017	UBS Group	Set Price Target	Buy	$89.00	N/A
2/2/2017	Robert W. Baird	Downgrade	Outperform ➝ Neutral	$86.00 ➝ $77.00	N/A
12/28/2016	Guggenheim	Reiterated Rating	Buy	$90.00	N/A
12/19/2016	Credit Suisse Group	Reiterated Rating	Buy		N/A
12/18/2016	Oppenheimer	Set Price Target	Buy	$88.00	N/A
12/13/2016	Guggenheim	Reiterated Rating	Buy	$90.00	N/A
12/12/2016	Jefferies Financial Group	Downgrade	Buy ➝ Hold	$122.00 ➝ $82.00	N/A
11/10/2016	Argus	Reiterated Rating	Buy	$120.00 ➝ $85.00	N/A
11/9/2016	Barclays	Reiterated Rating	Buy	$85.00	N/A
11/9/2016	SVB Leerink	Reiterated Rating	Buy	$105.00	N/A
11/9/2016	Mizuho	Boost Price Target	Buy	$90.00 ➝ $111.00	N/A
11/8/2016	Guggenheim	Reiterated Rating	Buy	$115.00 ➝ $90.00	N/A

(Data available from 10/21/2016 forward)

News Sentiment Rating

0.23 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

0 very positive mentions
30 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

3/25/2021

0 very positive mentions
18 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

4/24/2021

0 very positive mentions
24 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

5/24/2021

0 very positive mentions
11 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

6/23/2021

2 very positive mentions
33 positive mentions
4 negative mentions
2 very negative mentions

Mentions as of

7/23/2021

19 very positive mentions
36 positive mentions
10 negative mentions
1 very negative mentions

Mentions as of

8/22/2021

7 very positive mentions
39 positive mentions
5 negative mentions
1 very negative mentions

Mentions as of

9/21/2021

10 very positive mentions
32 positive mentions
6 negative mentions
2 very negative mentions

Mentions as of

10/21/2021

Current Sentiment

Recent Stories by Sentiment

CVS Health Corp. engages in the provision of health care services. It operates through the following segments: Pharmacy Services, Retail or Long Term Care, Health Care Benefits, and Corporate/Other. The Pharmacy Services segment offers pharmacy benefit management solutions. The Retail or Long Term Care segment includes selling of prescription drugs and assortment of general merchandise. The Health Care Benefits segment offers traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, medical management capabilities. The Corporate/Other segment involves in providing management and administrative services. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Today's Range

Now: $86.55

$85.00

$86.83

50 Day Range

MA: $84.83

$83.03

$87.47

52 Week Range

Now: $86.55

$55.36

$90.61

Volume

5,021,646 shs

Average Volume

6,252,262 shs

Market Capitalization

$114.21 billion

P/E Ratio

15.88

Dividend Yield

2.36%

Beta

0.83

Frequently Asked Questions

What sell-side analysts currently cover shares of CVS Health?: The following Wall Street analysts have issued stock ratings on CVS Health in the last twelve months: Barclays PLC, BMO Capital Markets, Cantor Fitzgerald, Citigroup Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Guggenheim, Jefferies Financial Group Inc., Mizuho, Morgan Stanley, Piper Sandler, Raymond James, Royal Bank of Canada, SVB Leerink LLC, Tigress Financial, Truist, Truist Securities, Wells Fargo & Company, and Wolfe Research.
View the latest analyst ratings for CVS.
What is the current price target for CVS Health?: 17 Wall Street analysts have set twelve-month price targets for CVS Health in the last year. Their average twelve-month price target is $94.71, suggesting a possible upside of 9.3%. Morgan Stanley has the highest price target set, predicting CVS will reach $114.00 in the next twelve months. Piper Sandler has the lowest price target set, forecasting a price of $76.00 for CVS Health in the next year.
View the latest price targets for CVS.
What is the current consensus analyst rating for CVS Health?: CVS Health currently has 4 hold ratings, 12 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CVS will outperform the market and that investors should add to their positions of CVS Health.
View the latest ratings for CVS.
What other companies compete with CVS Health?: Other companies that are similar to CVS Health include Walgreens Boots Alliance, Covetrus, Rite Aid, PetMed Express, 111, MedAvail, China Jo-Jo Drugstores, Progressive Care, HealthWarehouse.com, Dragon Jade International, Dougherty's Pharmacy, China Dasheng Biotechnology and Health Sciences Group.
How do I contact CVS Health's investor relations team?: CVS Health's physical mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator's listed phone number is (401) 765-1500 and its investor relations email address is [email protected] The official website for CVS Health is www.cvshealth.com.

NYSE:CVS - CVS Health Stock Price Target and Predictions

Analyst Price Target for CVS

Current Consensus is Buy

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.23 (Hold)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of CVS Health?

What is the current price target for CVS Health?

What is the current consensus analyst rating for CVS Health?

What other companies compete with CVS Health?

How do I contact CVS Health's investor relations team?